An Open Label Study to Evaluate G17DT Compared to Gemcitabine

Clinical trial NCT03200821 · COMPLETED

Trial details

NCT number: NCT03200821
Sponsor: Cancer Advances Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2000-08-14
Primary completion: 2001-09-24
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.